Timonium, MD, United States of America

Raymond Cheong

This inventor holds 1 USPTO granted patent. Top assignee: Euveda Biosciences, Inc.. Active years: 2017.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Raymond Cheong in Microfluidic Technology.

Introduction

Raymond Cheong is an accomplished inventor based in Timonium, MD (US). He has made significant contributions to the field of microfluidics, particularly in the design of devices that enhance high-throughput biochemical and cell-based assays. His innovative approach has the potential to revolutionize drug screening processes.

Latest Patents

Raymond Cheong holds a patent for a "Microfluidic grid-based design for high throughput assays." This patent describes a microfluidic device that resembles a microtiter plate, incorporating test chambers and drug inlets arranged in a grid format according to ANSI/SBS standards. The design offers the advantages of miniaturization and improved fluid handling, ensuring compatibility with existing drug screening equipment. The device allows for a variety of topologies and includes a resistance equalization methodology to minimize variability across different assay chambers. This innovation provides significant miniaturization compared to traditional multiwell plates and enhances the reliability of fluid handling.

Career Highlights

Raymond Cheong is currently employed at Euveda Biosciences, Inc., where he continues to develop cutting-edge technologies in the field of microfluidics. His work focuses on creating solutions that improve the efficiency and accuracy of biochemical assays.

Collaborations

Raymond collaborates with talented professionals such as Saurabh Paliwal and Zhizhong Yin, contributing to a dynamic research environment that fosters innovation and advancement in microfluidic technologies.

Conclusion

Raymond Cheong's contributions to microfluidic technology exemplify the impact of innovative design in enhancing drug screening processes. His patent and ongoing work at Euveda Biosciences, Inc. highlight his commitment to advancing the field and improving the efficiency of biochemical assays.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…